Garo H. Armen, Executive CHAIR & PRINCIPAL Officer at Protagenic Therapeutics, Inc.\new (PTIX), bought 2,220 shares at $0.32 ($710) on 2026-08-11, disclosed to the SEC on 2026-08-12.
Open-market purchase of $710 PTIX by Executive CHAIR & PRINCIPAL Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| PTIX | BUY | 2026-08-20 | $10K | — | Filing → |
| PTIX | BUY | 2026-08-10 | $151 | — | Filing → |
| PTIX | BUY | 2026-08-06 | $1K | — | Filing → |